Overview
- 6 public-safe observations are available for this inspection.
- 3 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
9 Jul 2015
21 CFR 820.198(a)
Lack of or inadequate complaint procedures
Cited by Lauren E Skokan Priest, Lauren E Skokan
9 Jul 2015
21 CFR 820.30(i)
Design changes - Lack of or Inadequate Procedures
Cited by Lauren E Skokan Priest, Lauren E Skokan
9 Jul 2015
21 CFR 820.70(i)
Software validation for automated processes
Cited by Lauren E Skokan Priest, Lauren E Skokan
9 Jul 2015
21 CFR 820.198(a)
Lack of or inadequate complaint procedures
Cited by Lauren E Skokan Priest, Lauren E Skokan
9 Jul 2015
21 CFR 820.30(i)
Design changes - Lack of or Inadequate Procedures
Cited by Lauren E Skokan Priest, Lauren E Skokan
Inspected site
BLbioLytical Laboratories, Inc.Richmond, Canada
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 820.198(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.30(i) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.70(i) | Cited across public-safe Form 483 observations | 2x |
Source document
PDF
PDF available
Form 483 source document
The source document is available to authorized Atlas users.
Full 483 report
Get the verbatim text of all 6 observations
The source PDF, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere